Y. Bayraktar et al., What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?, HEP-GASTRO, 45(24), 1998, pp. 2064-2072
BACKGROUND/AIMS: In the Western world, primary sclerosing cholangitis (PSC)
is a chronic cholestatic liver disease that is associated with inflammator
y bowel disease (IBD), particularly chronic ulcerative colitis and, to a le
sser degree, Crohn's disease. The goal of this study was to determine the p
revalence of PSC in Turkish patients with IBD and chronic amebic colitis, a
disease that is endemic in Turkey.
METHODOLOGY: During a 10-year period, between 1986 and 1996, a total of 81
IBD (64 ulcerative colitis and 17 Crohn's disease) patients and 127 patient
s with chronic amebic colitis were seen and evaluated with radiologic, sero
logic, immunologic and pathologic tests. Whenever a clinical or biochemical
finding suggested the presence of co-existent hepatic and/or biliary disea
se, the patient was further evaluated by liver biopsy, auto-antibodies and
endoscopic retrograde cholangiopancreatography (ERCP) to determine whether
they also had PSC or some other form of liver disease. As a disease control
group, a total of 752 patients with clinical and/or laboratory evidence of
pancreaticobiliary disease were also studied. In 86 of these 752 patients
(10%), a primary disorder of the biliary tree was diagnosed by ultrasonogra
phy, computed tomography, peritoneoscopy, liver biopsy, ERCP and abdominal
laparotomy. In addition, all 86 patients of the control group were evaluate
d endoscopically in order to determine whether they had any associated gast
rointestinal condition of the upper or lower gastrointestinal tracts. After
establishing final diagnoses of IBD, amebic colitis and PSC, these patient
s were evaluated with respect to their socio-economic status. A high protei
n diet (1.8gram/kg/day) was administered to those patients with chronic ame
bic colitis and IBD during the active period of the disease.
RESULTS: Of the 208 patients (81 with IBD and 127 with chronic amebic colit
is), no cases of PSC were identified. Of the 86 patients in the control gro
up with primary biliary tract disease, 45 had a biliary system malignancy,
14 had primacy biliary cirrhosis (PBC), 16 had PSC, 3 had Caroli's disease,
6 had a common bile duct cyst, and 2 had gallbladder adenomatosis. All but
1 of the 16 patients with PSC were female.
CONCLUSIONS: These data suggest that, in contrast to findings in Western Eu
rope and the USA, in Turkey: 1) PSC is not regularly associated with idiopa
thic IBD; 2) most patients with PSC are female; 3) PSC accounts for only 18
% of patients with a primary disorder of the biliary tree; 4) the incidence
of small-duct primary sclerosing cholangitis is greater than that reported
in the literature; and, 5) the incidence of IBD and PSC in Turkey is relat
ively lower than in other countries.